Anne Danks, Ph.D. Vice President of
Preclinical Development
Anne Danks, Ph.D.
Vice President of Preclinical Development
Dr. Danks joined DNS in 2009 to build, manage and direct drug discovery activities and preclinical development. She has over 20 years of pharmaceutical experience in discovering and evaluating small molecule drugs for a variety of CNS, oncology, inflammation and cardiovascular disorders. Prior to joining DNS, Dr. Danks was Senior Director of Pharmacology at TorreyPines Therapeutics, where she led the preclinical and discovery in vivo pharmacology, ADME and toxicology efforts for their anti-amyloid Alzheimer's Research program. She has also held positions of increasing responsibility at Merck Research Labs, SIBIA Neurosciences, Nereus Pharmaceuticals and Cypros Pharmaceuticals. Dr. Danks completed postdoctoral training at the University of California - Irvine after receiving her Ph.D. and M.A. degrees in Psychobiology from the State University of New York at Binghamton and B.A. in Psychology from Marquette University.